APA (7th ed.) Citation

Reich, K., Eyerich, K., Schäkel, K., Weisenseel, P., Pinter, A., Asadullah, K., . . . Taut, F. J. H. (2021). IL-23 blockade with guselkumab potentially modifies psoriasis pathogenesis: Rationale and study protocol of a phase 3b, randomised, double-blind, multicentre study in participants with moderate-to-severe plaque-type psoriasis (GUIDE). BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Reich, Kristian, et al. IL-23 Blockade with Guselkumab Potentially Modifies Psoriasis Pathogenesis: Rationale and Study Protocol of a Phase 3b, Randomised, Double-blind, Multicentre Study in Participants with Moderate-to-severe Plaque-type Psoriasis (GUIDE). BMJ Publishing Group, 2021.

MLA (8th ed.) Citation

Reich, Kristian, et al. IL-23 Blockade with Guselkumab Potentially Modifies Psoriasis Pathogenesis: Rationale and Study Protocol of a Phase 3b, Randomised, Double-blind, Multicentre Study in Participants with Moderate-to-severe Plaque-type Psoriasis (GUIDE). BMJ Publishing Group, 2021.